400 related articles for article (PubMed ID: 19264220)
21. [Current therapeutic approach to diabetic macular edema refractory to laser coagulation].
Davidescu L; Baltă F; Mocanu C; Puşcaşu CR; Olaru A
Oftalmologia; 2010; 54(2):91-8. PubMed ID: 20827918
[TBL] [Abstract][Full Text] [Related]
22. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.
; Beck RW; Edwards AR; Aiello LP; Bressler NM; Ferris F; Glassman AR; Hartnett E; Ip MS; Kim JE; Kollman C
Arch Ophthalmol; 2009 Mar; 127(3):245-51. PubMed ID: 19273785
[TBL] [Abstract][Full Text] [Related]
23. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema.
Kumar V; Ghosh B; Goel N
Am J Ophthalmol; 2009 Jul; 148(1):171; author reply 171-2. PubMed ID: 19540985
[No Abstract] [Full Text] [Related]
24. A new look at an old treatment for diabetic macular edema.
Schachat AP
Ophthalmology; 2008 Sep; 115(9):1445-6. PubMed ID: 18762072
[No Abstract] [Full Text] [Related]
25. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Ho TC; Lai WW; Lam DS
Am J Ophthalmol; 2006 Apr; 141(4):786-7; author reply 787-8. PubMed ID: 16564847
[No Abstract] [Full Text] [Related]
26. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Sarici A; Muftuoglu G
Am J Ophthalmol; 2006 Apr; 141(4):785-6; author reply 786. PubMed ID: 16564845
[No Abstract] [Full Text] [Related]
27. Optical coherence tomography.
Kumar A; Sinha S
Ophthalmology; 2008 Feb; 115(2):417-8; author reply 418. PubMed ID: 18243920
[No Abstract] [Full Text] [Related]
28. Diabetic macular edema.
Ghazi NG; Scruggs RT; Batchelet AR; Compton MW; Allam SS; Patrie J; Salti HI
Ophthalmology; 2012 Dec; 119(12):2643.e1. PubMed ID: 23207021
[No Abstract] [Full Text] [Related]
29. Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
Ockrim ZK; Sivaprasad S; Falk S; Roghani S; Bunce C; Gregor Z; Hykin P
Br J Ophthalmol; 2008 Jun; 92(6):795-9. PubMed ID: 18420749
[TBL] [Abstract][Full Text] [Related]
30. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Kumar V; Ghosh B; Raina UK; Goel N
Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427
[No Abstract] [Full Text] [Related]
31. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.
Zacks DN; Johnson MW
Retina; 2005; 25(2):135-40. PubMed ID: 15689801
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa.
Kim JE
Retina; 2006; 26(9):1094-6. PubMed ID: 17151506
[No Abstract] [Full Text] [Related]
33. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
[TBL] [Abstract][Full Text] [Related]
34. Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?
Iida T
Br J Ophthalmol; 2007 Apr; 91(4):407-8. PubMed ID: 17372335
[No Abstract] [Full Text] [Related]
35. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Nguyen QD; Shah SM; Khwaja AA; Channa R; Hatef E; Do DV; Boyer D; Heier JS; Abraham P; Thach AB; Lit ES; Foster BS; Kruger E; Dugel P; Chang T; Das A; Ciulla TA; Pollack JS; Lim JI; Eliott D; Campochiaro PA;
Ophthalmology; 2010 Nov; 117(11):2146-51. PubMed ID: 20855114
[TBL] [Abstract][Full Text] [Related]
36. A new approach to the management of diabetic macular edema.
Schachat AP
Ophthalmology; 2010 Jun; 117(6):1059-60. PubMed ID: 20522333
[No Abstract] [Full Text] [Related]
37. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Salti H; Farah T
Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
[No Abstract] [Full Text] [Related]
38. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
Imasawa M; Ohshiro T; Gotoh T; Imai M; Iijima H
Acta Ophthalmol Scand; 2005 Feb; 83(1):132-3. PubMed ID: 15715582
[No Abstract] [Full Text] [Related]
39. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.
Maia OO; Takahashi BS; Costa RA; Scott IU; Takahashi WY
Am J Ophthalmol; 2009 Feb; 147(2):291-297.e2. PubMed ID: 18929352
[TBL] [Abstract][Full Text] [Related]
40. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
